Unexpected efficacy signal identifies greater-than-anticipated therapeutic benefit warranting investigation. Off-target mechanism engagement produces additional benefits. Patient population enrichment explains enhanced response. Dosing regimen optimization improves efficacy. Biomarker discovery predicts responsive populations.
Clinical investigation characterises signal mechanisms. Regulatory notification informs about signal findings. Labelling updates communicate new indications. Post-approval exploration validates signal sustainability. Emerging populations may reveal additional benefits.
General Biopharmaceutical Concepts
Unexpected Efficacy Signal
An unexpected efficacy signal is an unanticipated therapeutic benefit observed during clinical development or post-marketing surveillance that warrants further investigation.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →